Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,010.00
+20.00 (0.29%)
At close: Apr 25, 2025, 3:30 PM KST

Daehan Nupharm Revenue

Daehan Nupharm had revenue of 14.55B KRW in the quarter ending September 30, 2013, with 12.73% growth. This brings the company's revenue in the last twelve months to 54.48B, up 19.23% year-over-year. In the year 2012, Daehan Nupharm had annual revenue of 48.01B with 7.83% growth.

Revenue (ttm)
54.48B
Revenue Growth
+19.23%
P/S Ratio
1.79
Revenue / Employee
238.93M
Employees
228
Market Cap
97.55B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 201248.01B3.49B7.83%
Dec 31, 201144.52B-5.12B-10.32%
Dec 31, 201049.65B9.24B22.88%
Dec 31, 200940.40B6.42B18.91%
Dec 31, 200833.98B-19.80B-36.82%
Dec 31, 2007 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 300.87T
SK hynix 66.19T
LG Energy Solution 25.62T
Samsung Biologics 4,547.32B
Hyundai Motor Company 178.98T
Hanwha Aerospace 11.24T
HD Hyundai Heavy Industries 14.49T
Kia Corporation 107.45T
Revenue Rankings